veltuzumab
Showing 1 - 4 of 4
Non Hodgkin's Lymphoma, NHL, Aggressive NHL Trial in United States (Veltuzumab and 90Y-Epratuzumab Tetraxetan, 90Y-epratuzumab
Withdrawn
- Non Hodgkin's Lymphoma
- +3 more
- Veltuzumab and 90Y-Epratuzumab Tetraxetan
- +2 more
-
Newark, Delaware
- +6 more
Aug 12, 2021
Non-Hodgkin's Lymphoma, Lymphoma, Diffuse, Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic Trial in Lille, Lyon, Leicester
Completed
- Non-Hodgkin's Lymphoma
- +2 more
- veltuzumab
-
Lille, Cedex, France
- +2 more
Aug 12, 2021
Follicular Lymphoma Trial in New York (90Y-epratuzumab tetraxetan, veltuzumab)
Terminated
- Follicular Lymphoma
- 90Y-epratuzumab tetraxetan
- veltuzumab
-
New York, New YorkWeill Cornell Medical College
Jan 26, 2018
Rheumatoid Arthritis Trial in Worldwide (Veltuzumab)
Terminated
- Rheumatoid Arthritis
- Veltuzumab
-
La Mesa, California
- +62 more
Mar 13, 2016